271.12
price up icon1.40%   3.74
after-market Dopo l'orario di chiusura: 271.12
loading
Precedente Chiudi:
$267.38
Aprire:
$266.52
Volume 24 ore:
649.88K
Relative Volume:
0.76
Capitalizzazione di mercato:
$22.48B
Reddito:
$13.48B
Utile/perdita netta:
$764.50M
Rapporto P/E:
29.90
EPS:
9.0688
Flusso di cassa netto:
$1.26B
1 W Prestazione:
-0.07%
1M Prestazione:
+6.79%
6M Prestazione:
+2.32%
1 anno Prestazione:
+8.59%
Intervallo 1D:
Value
$266.17
$271.73
Intervallo di 1 settimana:
Value
$264.80
$274.12
Portata 52W:
Value
$209.38
$293.72

Labcorp Holdings Inc Stock (LH) Company Profile

Name
Nome
Labcorp Holdings Inc
Name
Telefono
(336) 229-1127
Name
Indirizzo
358 S MAIN ST, BURLINGTON, NC
Name
Dipendente
70,000
Name
Cinguettio
@labcorp
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
LH's Discussions on Twitter

Confronta LH con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
LH
Labcorp Holdings Inc
271.12 22.17B 13.48B 764.50M 1.26B 9.0688
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
623.91 235.43B 43.74B 6.58B 6.11B 17.31
Diagnostics & Research icon
DHR
Danaher Corp
235.75 167.20B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
694.75 55.72B 4.17B 1.03B 940.22M 12.61
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
241.04 40.77B 15.90B 1.28B 2.21B 7.2842
Diagnostics & Research icon
A
Agilent Technologies Inc
135.95 38.46B 6.95B 1.30B 1.15B 4.5696

Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Downgrade HSBC Securities Buy → Hold
2025-04-02 Iniziato Redburn Atlantic Buy
2025-03-04 Aggiornamento Citigroup Neutral → Buy
2025-01-07 Aggiornamento Evercore ISI In-line → Outperform
2024-12-10 Ripresa Jefferies Buy
2024-10-30 Aggiornamento HSBC Securities Hold → Buy
2024-10-01 Iniziato Piper Sandler Neutral
2024-03-25 Aggiornamento Argus Hold → Buy
2024-02-26 Iniziato Leerink Partners Outperform
2024-02-09 Iniziato Evercore ISI In-line
2024-01-03 Iniziato Barclays Equal Weight
2023-09-06 Iniziato HSBC Securities Hold
2022-12-12 Downgrade Citigroup Buy → Neutral
2022-09-19 Downgrade Argus Buy → Hold
2022-08-22 Ripresa Morgan Stanley Overweight
2022-01-28 Downgrade Deutsche Bank Buy → Hold
2021-01-11 Aggiornamento Argus Hold → Buy
2021-01-11 Downgrade Wolfe Research Peer Perform → Underperform
2021-01-08 Downgrade Wolfe Research Outperform → Peer Perform
2020-07-14 Aggiornamento BofA Securities Neutral → Buy
2020-07-13 Aggiornamento Wolfe Research Peer Perform → Outperform
2020-06-02 Ripresa Deutsche Bank Buy
2020-05-15 Aggiornamento Mizuho Neutral → Buy
2020-04-29 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2020-04-27 Aggiornamento Citigroup Neutral → Buy
2020-04-27 Aggiornamento Wolfe Research Underperform → Peer Perform
2020-01-08 Iniziato Wells Fargo Overweight
2019-07-16 Aggiornamento BofA/Merrill Underperform → Neutral
2019-06-21 Aggiornamento Deutsche Bank Hold → Buy
2019-04-02 Aggiornamento Jefferies Hold → Buy
2019-01-17 Iniziato UBS Buy
2019-01-03 Downgrade BofA/Merrill Neutral → Underperform
2018-12-03 Downgrade Craig Hallum Buy → Hold
2018-10-30 Downgrade Argus Buy → Hold
2018-10-25 Downgrade Canaccord Genuity Buy → Hold
2018-10-19 Ripresa BofA/Merrill Buy
2018-06-07 Aggiornamento KeyBanc Capital Mkts Sector Weight → Overweight
2018-05-01 Aggiornamento Robert W. Baird Neutral → Outperform
2018-03-23 Iniziato Argus Buy
Mostra tutto

Labcorp Holdings Inc Borsa (LH) Ultime notizie

pulisher
Jan 26, 2026

Labcorp Holdings Inc. $LH Shares Sold by Cooke & Bieler LP - MarketBeat

Jan 26, 2026
pulisher
Jan 25, 2026

Sector Gamma AS Acquires 6,486 Shares of Labcorp Holdings Inc. $LH - MarketBeat

Jan 25, 2026
pulisher
Jan 25, 2026

Strs Ohio Reduces Stake in Labcorp Holdings Inc. $LH - MarketBeat

Jan 25, 2026
pulisher
Jan 24, 2026

Labcorp Holdings Inc. (NYSE:LH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 24, 2026
pulisher
Jan 24, 2026

Labcorp (NYSE:LH) Upgraded to Buy at Wall Street Zen - MarketBeat

Jan 24, 2026
pulisher
Jan 22, 2026

Expanded MRD Test Suite and Dividend Hike Might Change The Case For Investing In Labcorp (LH) - simplywall.st

Jan 22, 2026
pulisher
Jan 22, 2026

QRG Capital Management Inc. Has $878,000 Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

The Price Is Right For Labcorp Holdings Inc. (NYSE:LH) - 富途资讯

Jan 21, 2026
pulisher
Jan 20, 2026

Labcorp Holdings Inc. $LH Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat

Jan 20, 2026
pulisher
Jan 18, 2026

Navera Investment Management Ltd. Sells 11,643 Shares of Labcorp Holdings Inc. $LH - MarketBeat

Jan 18, 2026
pulisher
Jan 17, 2026

Community Health Completes Asset Sale to LabCorp - MSN

Jan 17, 2026
pulisher
Jan 17, 2026

Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72 - simplywall.st

Jan 17, 2026
pulisher
Jan 17, 2026

Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance

Jan 17, 2026
pulisher
Jan 17, 2026

Campbell & CO Investment Adviser LLC Invests $1.97 Million in Labcorp Holdings Inc. $LH - MarketBeat

Jan 17, 2026
pulisher
Jan 17, 2026

Ideas Watch: Can Labcorp Holdings Inc disrupt its industryPrice Action & Daily Growth Stock Tips - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Labcorp to Settle Patient Privacy Dispute Over Online Trackers - Bloomberg Law News

Jan 16, 2026
pulisher
Jan 16, 2026

Manning & Napier Advisors LLC Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat

Jan 16, 2026
pulisher
Jan 16, 2026

Labcorp’s quarterly earnings preview: What you need to know - MSN

Jan 16, 2026
pulisher
Jan 16, 2026

Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? - Yahoo Finance

Jan 16, 2026
pulisher
Jan 15, 2026

Labcorp Holdings Board Declares Quarterly Cash Dividend - The Globe and Mail

Jan 15, 2026
pulisher
Jan 15, 2026

Labcorp Schedules Q4 2025 Earnings Release and Call - TipRanks

Jan 15, 2026
pulisher
Jan 15, 2026

Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - Finviz

Jan 15, 2026
pulisher
Jan 15, 2026

Labcorp Holdings Inc to Announce Q4 2025 Financial Results - TradingView — Track All Markets

Jan 15, 2026
pulisher
Jan 15, 2026

A Look At Labcorp (LH) Valuation After Expanding Its MRD Cancer Testing Portfolio - Sahm

Jan 15, 2026
pulisher
Jan 15, 2026

Labcorp Declares Quarterly Dividend - Sahm

Jan 15, 2026
pulisher
Jan 15, 2026

Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria

Jan 15, 2026
pulisher
Jan 14, 2026

Labcorp Holdings Inc. to Issue Quarterly Dividend of $0.72 (NYSE:LH) - MarketBeat

Jan 14, 2026
pulisher
Jan 14, 2026

Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛

Jan 14, 2026
pulisher
Jan 14, 2026

Baird Adjusts Labcorp Price Target to $313 From $307, Maintains Outperform Rating - marketscreener.com

Jan 14, 2026
pulisher
Jan 14, 2026

Labcorp Holdings Inc. Declares Quarterly Dividend, Payable on March 12, 2026 - marketscreener.com

Jan 14, 2026
pulisher
Jan 14, 2026

Labcorp Holdings Maintains Quarterly Dividend of $0.72 a Share, Payable March 12 to Shareholders of Record as of Feb. 27 - marketscreener.com

Jan 14, 2026
pulisher
Jan 14, 2026

Labcorp declares quarterly dividend of $0.72 per share - Investing.com

Jan 14, 2026
pulisher
Jan 13, 2026

Labcorp’s Expanded Plasma Detect MRD Portfolio Could Be A Game Changer For Labcorp Holdings (LH) - Sahm

Jan 13, 2026
pulisher
Jan 13, 2026

Labcorp expands cancer recurrence testing for breast, lung, colon cancers By Investing.com - Investing.com Canada

Jan 13, 2026
pulisher
Jan 13, 2026

Labcorp expands cancer recurrence testing for breast, lung, colon cancers - Investing.com

Jan 13, 2026
pulisher
Jan 13, 2026

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk - Finviz

Jan 13, 2026
pulisher
Jan 13, 2026

Labcorp Holdings Inc. $LH Shares Sold by Nordea Investment Management AB - MarketBeat

Jan 13, 2026
pulisher
Jan 13, 2026

Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk (2026-01-13) - Seeking Alpha

Jan 13, 2026
pulisher
Jan 13, 2026

Assessing Labcorp Holdings (LH) Valuation After A Recent 10.5% Three Month Share Price Decline - Yahoo Finance

Jan 13, 2026
pulisher
Jan 12, 2026

Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.

Jan 12, 2026
pulisher
Jan 11, 2026

SG Americas Securities LLC Acquires 17,723 Shares of Labcorp Holdings Inc. $LH - MarketBeat

Jan 11, 2026
pulisher
Jan 10, 2026

Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? - MSN

Jan 10, 2026
pulisher
Jan 10, 2026

Will Labcorp Holdings Inc. stock outperform tech sector in 2025Market Risk Summary & Community Supported Trade Ideas - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC - MarketBeat

Jan 10, 2026
pulisher
Jan 10, 2026

Labcorp (NYSE:LH) Downgraded by Wall Street Zen to "Hold" - MarketBeat

Jan 10, 2026
pulisher
Jan 09, 2026

Labcorp’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance

Jan 09, 2026
pulisher
Jan 09, 2026

NAMSA acquires Labcorp’s medical device testing assets - Yahoo Finance

Jan 09, 2026
pulisher
Jan 09, 2026

Is Labcorp Holdings Inc. stock worth holding before Fed meetingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru

Jan 09, 2026
pulisher
Jan 08, 2026

Is Labcorp Holdings Inc. stock supported by strong cash flowsBreakout Watch & Weekly High Return Forecasts - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Labcorp Holdings Stock: Analyst Estimates & Ratings - MSN

Jan 08, 2026
pulisher
Jan 08, 2026

Can Labcorp Holdings Inc. stock beat market expectations this quarterQuarterly Investment Review & AI Powered Buy and Sell Recommendations - Улправда

Jan 08, 2026

Labcorp Holdings Inc Azioni (LH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research WAT
$390.09
price down icon 0.21%
$152.09
price down icon 0.59%
diagnostics_research MTD
$1,425.18
price down icon 0.03%
$240.34
price down icon 0.43%
diagnostics_research A
$135.95
price up icon 0.22%
Capitalizzazione:     |  Volume (24 ore):